Here's the live share price of Neuland Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Neuland Laboratories has gained 71.62% CAGR. Over the past year, the corresponding return has been 13.48%.
Neuland Laboratories’s current P/E of 106.57x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Neuland Laboratories | 7.89 | 13.21 | 23.52 | 22.83 | 13.48 | 128.56 | 71.62 |
Sun Pharmaceutical Industries | 0.04 | -2.29 | -5.26 | 0.81 | -12.60 | 21.69 | 25.45 |
Divi's Laboratories | -1.78 | -6.24 | -9.36 | 8.98 | 17.24 | 18.68 | 13.45 |
Cipla | -2.32 | 3.57 | 4.23 | 9.46 | -4.63 | 14.82 | 16.72 |
Torrent Pharmaceuticals | 0.62 | -0.23 | 13.90 | 20.10 | 4.02 | 33.07 | 20.80 |
Dr. Reddy's Laboratories | 0.44 | 4.51 | -1.66 | 12.60 | -5.30 | 14.60 | 7.48 |
Mankind Pharma | 3.23 | -2.51 | 8.05 | 11.49 | 3.27 | 21.45 | 12.37 |
Zydus Lifesciences | 3.40 | 5.63 | 6.13 | 14.26 | -9.05 | 39.82 | 22.33 |
Lupin | 2.27 | 3.90 | -2.97 | -3.66 | -15.39 | 43.67 | 15.92 |
Abbott India | -0.79 | -6.05 | -1.42 | -0.43 | 5.42 | 19.72 | 13.68 |
Alkem Laboratories | 0.58 | 8.45 | 10.17 | 13.64 | -15.02 | 20.67 | 13.59 |
Aurobindo Pharma | 1.69 | -3.24 | -9.87 | -4.33 | -31.81 | 24.63 | 5.64 |
Glenmark Pharmaceuticals | 6.87 | 0.24 | 29.73 | 48.29 | 20.31 | 76.91 | 34.51 |
Biocon | 4.45 | -2.35 | 10.03 | 12.06 | -4.96 | 7.51 | -2.93 |
Laurus Labs | 2.74 | 2.62 | 37.33 | 55.29 | 79.92 | 16.07 | 29.66 |
GlaxoSmithKline Pharmaceuticals | -0.24 | -2.23 | -19.74 | 3.15 | -1.27 | 24.44 | 11.30 |
Anthem Biosciences | 1.37 | 12.75 | 13.61 | 13.61 | 13.61 | 4.35 | 2.58 |
Cohance Lifesciences | 5.19 | -3.75 | -12.98 | -21.28 | -19.61 | 23.33 | 22.36 |
Ipca Laboratories | -3.18 | -6.24 | -3.59 | -1.93 | -7.37 | 14.67 | 5.57 |
Ajanta Pharma | 5.65 | -0.67 | 1.69 | 2.28 | -21.34 | 24.71 | 20.83 |
Over the last one year, Neuland Laboratories has gained 13.48% compared to peers like Sun Pharmaceutical Industries (-12.60%), Divi's Laboratories (17.24%), Cipla (-4.63%). From a 5 year perspective, Neuland Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (25.45%) and Divi's Laboratories (13.45%).
Day | SMA | EMA |
---|---|---|
5 | 13,607.86 | 14,056.27 |
10 | 13,611.38 | 13,792.06 |
20 | 13,342.01 | 13,588.67 |
50 | 13,155.14 | 13,249.14 |
100 | 12,659.49 | 12,948.72 |
200 | 13,091.1 | 12,476.59 |
In the latest quarter, Neuland Laboratories remained same as its previous close in promoter holding, while DII stake increased to 11.57%, FII holding fell to 21.69%, and public shareholding moved down to 33.67% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
ICICI Prudential Flexicap Fund | 2,37,673 | 1.76 | 315.65 |
HSBC Small Cap Fund - Regular Plan | 2,06,718 | 1.66 | 274.54 |
Bandhan Small Cap Fund | 60,062 | 0.57 | 79.77 |
Sundaram Small Cap Fund | 44,855 | 1.76 | 59.57 |
Mahindra Manulife Large & Mid Cap Fund | 27,800 | 1.37 | 36.92 |
Mahindra Manulife Multi Cap Fund | 26,000 | 0.6 | 34.53 |
PGIM India Flexi Cap Fund | 25,605 | 0.54 | 34.01 |
ITI Small Cap Fund | 25,255 | 1.25 | 33.54 |
HSBC Focused Fund | 25,000 | 1.97 | 33.2 |
Mahindra Manulife Small Cap Fund | 19,685 | 0.65 | 26.14 |
Date Time | Announcement |
---|---|
Aug 30, 2025, 7:27 PM IST | Neuland Laborat - Intimation Under Regulation 30 Of SEBI Listing Regulations |
Aug 26, 2025, 6:41 PM IST | Neuland Laborat - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot |
Aug 20, 2025, 4:27 PM IST | Neuland Laborat - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Aug 05, 2025, 9:47 PM IST | Neuland Laborat - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Aug 04, 2025, 11:03 PM IST | Neuland Laborat - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 1476.84 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Neuland Laboratories is ₹14,519.00 as on Sep 05, 2025.
The Neuland Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Neuland Laboratories is ₹18,627.72 Cr as on Sep 05, 2025.
Today’s highest and lowest price of Neuland Laboratories are ₹15,060.90 and ₹14,387.65.
The 52-week high/low is the highest and lowest price at which Neuland Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Neuland Laboratories is ₹18,089.55 and 52-week low of Neuland Laboratories is ₹10,060.00 as on Sep 05, 2025.
The Neuland Laboratories has shown returns of -0.59% over the past day, 13.21% for the past month, 23.52% over 3 months, 13.48% over 1 year, 128.56% across 3 years, and 71.62% over 5 years.
P/E ratio of and PB ratio of Neuland Laboratories are 106.57 and 13.42 on Sep 05, 2025. While the company gives a dividend yield of 0.08 per annum.